Concepedia

Matthew E. Barton

ME

21

Publications

1.3K

Citations

17

H-Index

2001

Active since

Affiliations

Research Triangle Park Foundation(Current)

GlaxoSmithKline (United Kingdom)

GlaxoSmithKline (United States)

Eli Lilly (United States)

Age UK

Matthew E. Barton is an author at Research Triangle Park Foundation specializing in medicine, pharmacology, and neuropharmacology.

Top concepts

Publications per year

2001–2019

21

Publications

21

Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy

Matthew E. Barton, Brian D. Klein, Harold H. Wolf et al. · Epilepsy Research · 2001 · 605 citations

, , +13

Comparison of the effect of glutamate receptor modulators in the 6 Hz and maximal electroshock seizure models

Matthew E. Barton, Steven Peters, Harlan E. Shannon · Epilepsy Research · 2003 · 111 citations

, , +12

The antihyperalgesic effects of the T-type calcium channel blockers ethosuximide, trimethadione, and mibefradil

Matthew E. Barton, Elizabeth L. Eberle, Harlan E. Shannon · European Journal of Pharmacology · 2005 · 60 citations

, , +10

Constitutive deletion of the serotonin-7 (5-HT7) receptor decreases electrical and chemical seizure thresholds

Jeffrey M. Witkin, Melvyn Baez, Jianliang Yu et al. · Epilepsy Research · 2007 · 47 citations

, , +12

Modulation of LPS-induced pulmonary neutrophil infiltration and cytokine production by the selective PPARβ/δ ligand GW0742

Zdenka Hašková, Bao Hoang, Guo-Lun Luo et al. · Inflammation Research · 2008 · 45 citations

, , +9

Rows per page

1–5 of 21